Reaching the Unreachable: How We Scaled a Legacy Pain Relief Brand Across Four Indian States Without a Single MR” / Uncategorized / By dkdipanshu@gmail.com In 2021–2023, our team partnered with one of India’s most prescribed diclofenac-based pain management brands, originally owned by a leading Swiss multinational pharma company and later acquired by a prominent Indian pharma major.The brand had exceptional nationwide recall, but penetration into low-priority rural and semi-urban territories remained limited — largely due to high field-force costs and diminishing ROI in underserved regions.Our objective was to reignite grassroots-level demand across Gujarat, Telangana, Andhra Pradesh, and Bihar — without deploying a single traditional Medical Representative (MR).Text Submit Related
